Presentation Information
[1-MO01-04]11C-Labeling and evaluation of a 2-methylaminopyrimidine scaffold compound targeting LRRK2
Wakana Mori1, Nobuki Nengaki1,2, Masanao Ogawa1,2, Tomoteru Yamasaki1, Masayuki Fujinaga1, Tatsuya Kikuchi1, Ming-Rong Zhang1 (1.Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology., Chiba, Japan, 2.SHI Accelerator Service Ltd., Tokyo, Japan)